Recent BioUtah News & Events

Utah’s life sciences community is an economic force, with over 1,000 companies, employing 130,000 Utahns, directly and indirectly, and generating $13  billion in GDP. 

Patented LivRingTM is an intravaginal ring that provides long-lasting, controlled release of moisture to supplement the body’s natural lubrication and enhance the ease and comfort of sexual activity.

Thermo Fisher Scientific received emergency use authorization from the U.S. Food and Drug Administration to run COVID-19 tests from saliva samples collected with the Spectrum Solutions SpectrumDNA SDNA-1000 collection device on the Amplitude Solution.

ARUP Laboratories recently announced that it will increase its minimum hourly wage

Utah legislators on Wednesday kicked-off the new Utah Life Sciences Innovation Caucus (ULSIC) with a meeting at the state capitol.

Renalytix recently announced its results for the twelve months ended 30 June 2021.

Scientists in the United States and Iceland who are collecting and studying DNA as part of the HerediGene: Population Study, have discovered the genetic underpinnings of vertigo.

IONIQ Sciences Announces the Appointment of Aaron B. Dorny to its Board of Directors.

Biomerieux, which includes US-based BioFire, announced Q3 sales growth at 11.6%, significantly above expectations due, in part, to a strong upturn in US respiratory panels demand.

SpermQT analyzes the molecular function of sperm and is 6x more predictive of fertility potential than standard semen analysis.

Utah Business is proud to present its annual 40 Under 40 event that will be held in February 2022.

BioUtah member Discgenics Chairman and CEO Flagg Flanagan Among 100 Most Intriguing Entrepreneurs at 2021 Builders + Innovators Summit.

VIA ELECTRONIC SUBMISSION October 15, 2021  The Honorable Chiquita Brooks-LaSure Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services  Attention: CMS-3372-P2 P.O. Box 8013 Baltimore, MD 21244–8013  Re: Medicare Program; Medicare Coverage of Innovative Technology (MCIT) and Definition of “Reasonable and Necessary” Proposed Rule: [CMS-3372-P2] Dear Administrator Brooks-LaSure: BioUtah appreciates the […]

The BioHive Summit, powered in partnership with BioUtah, on Nov. 12 will live stream a distinguished line-up of speakers and panelists from inside and outside Utah’s burgeoning life sciences industry.

Join WTC Utah in Dubai, UAE for the largest U.S. government-led trade mission and business development forum.

Grants Totaling Over $3M Earmarked for Life Saving Medical Technology to Combat Massive Blood Loss

A clinical stage ophthalmology company, iVeena is developing disease-modifying therapeutics for a rare corneal disorder and an increasingly common form of nearsightedness

Yesterday, US Rep. Blake Moore (R-UT-1) visited the burgeoning BioHive community in Logan, touring Utah State University’s (USU0 state-of-the-art BioInnovations Center, Quansys Biosciences and ELITech. Utah’s life sciences industry, from Logan to St. George, is one of the fastest-growing in the nation. “Cache Valley has become a hub for bioscience, and I thank BioUtah for […]

SALT LAKE CITY, Oct. 7, 2021 /PRNewswire/ — PolarityTE, Inc. (Nasdaq: PTE) a biotechnology company developing regenerative tissue products and biomaterials, today provided an update regarding its Investigational New Drug Application (IND) for SkinTE® with a proposed indication for chronic cutaneous ulcers submitted to the Food and Drug Administration (FDA) in July 2021. The Company received […]

NEW YORK and SALT LAKE CITY, Oct. 07, 2021 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the expansion of its commercial strategy to address early-stage kidney disease in the Veterans Health Administration patient population with the appointment of Jed Fulk to the position of Vice President Sales, Government Accounts. Mr. Fulk […]

Stryker CEO, Kevin Lobo, recently shared his thoughts about his work at Stryker and what it means to help make a difference for patients

BioHive, Utah’s collective of life sciences and healthcare innovation companies, today announced that Katelin Roberts will serve as the full time Executive Director, effective immediately.

Recursion announced that the U.S. Food and Drug Administration (FDA) has granted the company orphan drug designation for REC-4881 for the potential treatment of familial adenomatous polyposis (FAP).

SINTX Technologies, Inc., an original equipment manufacturer of advanced ceramics, announced today a Phase 1 grant of $308,301 awarded by the National Institute of Health (NIH) to develop a 3-D printed, composite silicon nitride – polyetheretherketone (SN-PEEK) spinal implant.